19
Views
10
CrossRef citations to date
0
Altmetric
Original Article

Treatment of Hairy Cell Leukaemia with 2′-Deoxycoformycin

&
Pages 179-185 | Received 31 Jul 1989, Published online: 01 Jul 2009

References

  • Bouroncle B. A., Wiseman B. K., Doan C. A. Leukemic reticuloendotheliosis. Blood 1958; 13: 609–30
  • Jansen J., Hermans J. For the collaborative study group. Splenectomy in hairy cell leukemia. A retrospective multi-center analysis. Cancer 1981; 47: 2066–76
  • Golomb H. M., Mintz U. Treatment of hairy cell leukemia (leukemic reticuloendotheliosis). II. Chlorambucil therapy in postsplenectomy patients with progressive disease. Blood 1979; 54: 305–9
  • Cold S., Brincker H. Chemotherapy of progressive hairy cell leukaemia. European Journal of Haematology 1987; 38: 251–5
  • Quesada J. R., Hersh E. M., Manning J. Treatment of hairy cell leukemia with recombinant a-Interferon. Blood 1986; 68: 493–7
  • Golomb H. M., Jacobs A., Fefer A. Alpha-2 Interferon therapy of hairy cell leukaemia: a multicenter study of 64 patients. Journal of Clinical Oncology 1986; 4: 900–5
  • Worman C. P., Catovsky D., Cawley J. C. The UK experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases. Leukemia 1987; 1: 320–2
  • Quesada J. R., Lepe-Zuniga J. L., Gutterman J. U. Mid-term observations on the efficacy of α-interferon in hairy cell leukemia and status of the interferon system of patients in remission. Leukemia 1987; 1: 317–9
  • Johnston J. B., Glazer R. I., Pugh L., Israels L. G. The treatment of hairy-cell leukaemia with 2′-deoxycoformycin. British Journal of Haematology 1986; 63: 525–34
  • Foon K. A., Nakano G. M., Koller C. A., Longo D. L., Steis R. G. Response to 2′-deoxycoformycin after failure of interferon-cc in nonsplenectomised patients with hairy cell leukemia. Blood 1986; 68: 297–300
  • Kraut E. H., Bouroncle B. A., Grever M. R. Low-dose deoxycoformycin in the treatment of hairy cell leukemia. Blood 1986; 68: 1119–22
  • Spiers A. S. D., Moore D., Cassileth P. A. Remissions in hairy cell leukemia with pentostalin (2′-deoxyco-formycin). New England Journal of Medicine 1987; 316: 825–30
  • Ikartien C., Catovsky D. Current treatment of hairy cell leukaemia. European Journal of Haematology 1988; 41: 183–6
  • Grem J. L., King S. A., Cheson B. D., Leyland-Jones B., Wittes R. E. Pentostatin in hairy cell leukemia: treatment by the special exception mechanism. Journal of the National Cancer Institute 1989; 81: 448–53
  • Smyth J. F., Paine R. M., Jackman A. L. The clinical pharmacology of the adenosine deaminase inhibitor 2-deoxycoformycin. Cancer Chemotherapy and Pharmacology 1980; 5: 93–101
  • Mitchell B. S., Edwards N. L., Koller C. A. Deoxyribonucleotide triphosphate accumulation by leukemic cells. Blood 1983; 62: 419–424
  • Grever M. R., Siaw M. F. E., Jacob W. F. The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Blood 1981; 57: 406–17
  • Ho A. D., Ganeshaguru K., Knauf W. U. Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells. in vivo. Blood 1988; 72: 1884–90
  • Siaw M. F. E., Mitchell B. S., Koller C. A., Coleman M. S., Hutton J. J. ATP depletion as a consequence of adenosine deaminase inhibition in man. Proceedings of the National Academy of Science, USA 1980; 77: 6157–6161
  • Matsumoto S. S., Yu J., Yu A. L. Inhibition of RNA synthesis by deoxyadenosine plus deoxycoformycin in resting lymphocytes. Journal of Immunology 1983; 131: 2762–2766
  • Begleiter A., Glazer R. I., Israels L. G., Pugh L., Johnston J. H. Induction of DNA strand breaks in chronic lymphocytic leukemia following treatment with 2′-deoxycofor-mycin in vivo and. in vitro. Cancer Research 1987; 47: 2498–2503
  • Lamballe F., Le Prise P.-Y., Le Gall E., David J.-C. dATP-mediated inhibition of DNA ligase by 2′-deoxycoformycin in T and B cell leukemia. Leukemia 1989; 3: 97–103
  • Siaw M. F. E., Coleman M. S. In vitro metabolism of deoxycoformycin in human T lymphoblastoid cells. Journal of Bid Chem. 1984; 259: 9426
  • Seto S., Carrera C. J., Kubota M., Wasson W., Carson D. A. Mechanism of deoxyadenosine and 2′-chloratieoxya-denosine toxicity to non-dividing human lymphocytes. Journal of Clinical Investigation 1985; 75: 377–82
  • Dissing J., Knudsen B. Adenosine deaminase deficiency and combined immunodeficiency syndrome. Lancet 1972; ii: 1316
  • Hoffbrand A. V., Ma D. D. F., Webster A. D. B. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukemias and immunodeficiency syndromes. Clinical Haematology 1982; 11: 719–741
  • Smyth J., Poplack D. G., Holiman B. J., Leventhal B. G., Yarbro G. Correlation of adenosine deaminase activity with surface markers in acute lymphoblastic leukemia. Journal of Clinical Investigation 1978; 62: 710–712
  • Smyth J. F., Prentice H. G., Proctor S., Hoffbrand A. V. Deoxycoformycin in the treatment of leukemias and lymphomas. Annals of the New York Academy of Science 1986; 451: 123–8
  • O'Dwyer P. J., Wagner B., Leyland-Jones B. 2′-deoxycoformycin (Pentostatin) for lymphoid malignancies. Rational development of an active new drug. Annals of Internal Medicine 1988; 108: 733–743
  • Grever M. R., Leiby J. M., Kraut E. H. Low-dose deoxycoformycin in lymphoid malignancy. Journal of Clinical Oncoloyy 1985; 3: 1196–210
  • Matutes E., Worner I., Sainati L., De Oliveira M. P., Catovsky D. Advances in the lymphoproliferative disorders. Review of our experience in the study of over 1000 cases. Biol. Clin. Haematol. 1989; 11: 53–62
  • O'Dwyer P. J., Spiers A. S. D., Marsoni S. Association of severe and fatal infections and treatment with Pentostatin. Cancer Treatment Reports 1986; 70: 1111–1120
  • Urba W. J., Baseler M. W., Kopp W. C. Deoxycoformycin induced immunosuppression in patients with hairy cell leukemia. Blood 1989; 73: 38–46

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.